A new artificial intelligence (AI) tool is on the verge of revolutionising how general practitioners (GPs) operate, potentially reducing wait times significantly in medical practices across Australia. However, comparisons to “Dr Google” may not fully encapsulate its capabilities, as explained by Dr Michael Wright, President of the Royal Australian College of General Practitioners (RACGP).
Australian GPs have long utilised online resources to remain informed about the latest medical developments; clinical AI platforms are seen as an evolution of this practice. Dr Wright noted that GPs are exploring AI to enhance efficiency and improve the quality of care, though the integration of such tools is not mandatory. Currently, approximately 40% of Australian GPs are employing AI scribe tools to optimise consultations, and many will soon have access to a new platform called MedLuma.
Co-founded by Dr Stephen Barnett, a Clinical Associate Professor at the University of Wollongong, MedLuma is designed to help GPs quickly retrieve the latest medical information. It aggregates Australian clinical guidelines, peer-reviewed research, RACGP-approved materials, and international literature to assist GPs in addressing patient queries. The tool aims to streamline searches, alleviating the burden on overworked doctors who often find themselves juggling multiple tabs and sources for information.
With the medical literature constantly expanding—over a million articles are released annually—keeping abreast of new developments can be overwhelming for GPs. Set to launch on approximately 40,000 GP desktops this August, MedLuma seeks to expedite the search process and enhance patient consultations.
While some patients have begun using AI tools like ChatGPT and Claude for medical inquiries, there is a growing hesitance among others regarding the role of AI in healthcare. Concerns about data privacy and the reliability of AI-generated information have led to a vocal opposition among certain groups. AI’s propensity for error—often referred to as “hallucination”—raises valid questions about its application in clinical settings.
MedLuma assures users that it employs human clinical validators to ensure the accuracy of its data and has protocols in place to protect patient privacy. Dr Wright has encouraged patients to voice any concerns they may have about AI usage during their medical appointments.
The trend towards incorporating clinical AI tools like MedLuma appears to be escalating, with the RACGP and other health agencies working on establishing guidelines for their use. As Dr Wright emphasised, the priority remains patient safety and care. The broader public’s response to AI integration in medical practices remains to be seen, but the transition is already underway.